12:00 AM
 | 
Dec 14, 2009
 |  BC Week In Review  |  Company News  |  Deals

Ablynx, Boehringer Ingelheim deal

Ablynx will receive €3 million ($4.4 million) in milestone payments from Boehringer under a 2007 deal to use Ablynx's Nanobody technology to...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >